JPS5813508A - ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物 - Google Patents

ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物

Info

Publication number
JPS5813508A
JPS5813508A JP10977781A JP10977781A JPS5813508A JP S5813508 A JPS5813508 A JP S5813508A JP 10977781 A JP10977781 A JP 10977781A JP 10977781 A JP10977781 A JP 10977781A JP S5813508 A JPS5813508 A JP S5813508A
Authority
JP
Japan
Prior art keywords
drug
pgfae
soluble drug
powder
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10977781A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0474339B2 (enrdf_load_stackoverflow
Inventor
Akira Akazawa
赤沢　明
Shimesu Motoyama
本山　示
Satoru Sato
哲 佐藤
Seiichi Umeda
誠一 梅田
Hirotsune Yasumi
普恒 八隅
Emiko Sudo
須藤　恵美子
Takuichi Tsujino
辻野　拓一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUROINTO SANGYO KK
Taiho Pharmaceutical Co Ltd
Freund Corp
Original Assignee
FUROINTO SANGYO KK
Taiho Pharmaceutical Co Ltd
Freund Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUROINTO SANGYO KK, Taiho Pharmaceutical Co Ltd, Freund Corp filed Critical FUROINTO SANGYO KK
Priority to JP10977781A priority Critical patent/JPS5813508A/ja
Priority to DE19823224619 priority patent/DE3224619A1/de
Priority to CH4123/82A priority patent/CH652307A5/de
Priority to KR8203134A priority patent/KR880000970B1/ko
Publication of JPS5813508A publication Critical patent/JPS5813508A/ja
Priority to US06/724,502 priority patent/US4751241A/en
Publication of JPH0474339B2 publication Critical patent/JPH0474339B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP10977781A 1981-07-14 1981-07-14 ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物 Granted JPS5813508A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP10977781A JPS5813508A (ja) 1981-07-14 1981-07-14 ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物
DE19823224619 DE3224619A1 (de) 1981-07-14 1982-07-01 Orale pharmazeutische zusammensetzung
CH4123/82A CH652307A5 (de) 1981-07-14 1982-07-06 Pharmazeutische zusammensetzung fuer die orale anwendung.
KR8203134A KR880000970B1 (ko) 1981-07-14 1982-07-14 생물학적 유용성이 높은 경구용 약학적 조성물의 제조방법
US06/724,502 US4751241A (en) 1981-07-14 1985-04-19 Pharmaceutical composition of cyclandelate having a high degree of bioavailability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10977781A JPS5813508A (ja) 1981-07-14 1981-07-14 ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物

Publications (2)

Publication Number Publication Date
JPS5813508A true JPS5813508A (ja) 1983-01-26
JPH0474339B2 JPH0474339B2 (enrdf_load_stackoverflow) 1992-11-26

Family

ID=14518957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10977781A Granted JPS5813508A (ja) 1981-07-14 1981-07-14 ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物

Country Status (1)

Country Link
JP (1) JPS5813508A (enrdf_load_stackoverflow)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910505A (ja) * 1982-07-07 1984-01-20 Nisshin Oil Mills Ltd:The 油状美白化粧料
JPS6185328A (ja) * 1984-10-02 1986-04-30 Kao Corp 経皮吸収促進剤及びこれを含有する皮膚外用剤
JPS6185332A (ja) * 1984-10-04 1986-04-30 Kao Corp 経粘膜吸収促進剤及びこれを含有する経粘膜投与用製剤
JPS6245513A (ja) * 1985-08-23 1987-02-27 Taiyo Kagaku Kk 歯磨組成物
JPS6267019A (ja) * 1985-09-18 1987-03-26 Nisshin Kagaku Kk 自己乳化型軟カプセル薬液
JPS62294612A (ja) * 1986-06-16 1987-12-22 Eisai Co Ltd 吸収性の改良されたメナテトレノン含有組成物
JPH01128921A (ja) * 1987-11-12 1989-05-22 Taisho Pharmaceut Co Ltd ビタミンｅの吸収促進製剤
JPH06145042A (ja) * 1992-11-06 1994-05-24 Kao Corp 浴剤組成物
US5385737A (en) * 1992-06-12 1995-01-31 Kao Corporation Surfactant-containing seamless capsules
US5399357A (en) * 1988-11-08 1995-03-21 Takeda Chemical Industries, Ltd. Sustained release preparations
WO1998053797A3 (de) * 1997-05-28 1999-03-11 Ifac Inst Fuer Angewandte Coll Einkapseln von wasserunlöslichen wirkstoffen mit amphiphilem charakter
EP0866697A4 (en) * 1996-07-24 2006-01-18 Biosytes Usa Inc METHOD OF INCREASING THE SOLVENT PROPERTIES OF RELATIVELY UNLESHLY DIET ADDITIVES AND THESE PRODUCTS CONTAINING THEREOF
JP2006521366A (ja) * 2003-03-28 2006-09-21 シグモイド・バイオテクノロジーズ・リミテッド シームレスマイクロカプセルを含む固形経口剤形
JP2006306819A (ja) * 2005-05-02 2006-11-09 Kenji Nakamura シート状化粧料
JP2007302585A (ja) * 2006-05-10 2007-11-22 Fuji Capsule Kk コエンザイムｑ１０含有飲食品及び医薬品
WO2008047559A1 (fr) 2006-10-16 2008-04-24 Freund Corporation Poudre fortement dispersible dans l'eau et son procédé de production
JP2008520563A (ja) * 2004-11-16 2008-06-19 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
JPWO2009001786A1 (ja) * 2007-06-22 2010-08-26 株式会社カネカ 生理活性物質含有組成物
US8388950B2 (en) 2005-06-15 2013-03-05 Kaneka Corporation Coenzyme Q10-containing water-soluble composition and process for production thereof
US9675558B2 (en) 2007-04-04 2017-06-13 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US9821024B2 (en) 2010-11-25 2017-11-21 Sigmoid Pharma Limited Immunomodulatory compositions
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
US9950051B2 (en) 2012-07-05 2018-04-24 Sigmoid Pharma Limited Formulations
US9999651B2 (en) 2009-05-18 2018-06-19 Sigmoid Pharma Limited Composition comprising oil drops
US10434138B2 (en) 2013-11-08 2019-10-08 Sublimity Therapeutics Limited Formulations
US10993987B2 (en) 2014-11-07 2021-05-04 Sublimity Therapeutics Limited Compositions comprising Cyclosporin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4889262B2 (ja) 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS *
THE LNDION JOURNAL OF PHARMACY=1978 *

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5910505A (ja) * 1982-07-07 1984-01-20 Nisshin Oil Mills Ltd:The 油状美白化粧料
JPS6185328A (ja) * 1984-10-02 1986-04-30 Kao Corp 経皮吸収促進剤及びこれを含有する皮膚外用剤
JPS6185332A (ja) * 1984-10-04 1986-04-30 Kao Corp 経粘膜吸収促進剤及びこれを含有する経粘膜投与用製剤
JPS6245513A (ja) * 1985-08-23 1987-02-27 Taiyo Kagaku Kk 歯磨組成物
JPS6267019A (ja) * 1985-09-18 1987-03-26 Nisshin Kagaku Kk 自己乳化型軟カプセル薬液
JPS62294612A (ja) * 1986-06-16 1987-12-22 Eisai Co Ltd 吸収性の改良されたメナテトレノン含有組成物
JPH01128921A (ja) * 1987-11-12 1989-05-22 Taisho Pharmaceut Co Ltd ビタミンｅの吸収促進製剤
US5593690A (en) * 1988-11-08 1997-01-14 Takeda Chemical Industries, Ltd. Sustained release preparations
US5399357A (en) * 1988-11-08 1995-03-21 Takeda Chemical Industries, Ltd. Sustained release preparations
US5385737A (en) * 1992-06-12 1995-01-31 Kao Corporation Surfactant-containing seamless capsules
JPH06145042A (ja) * 1992-11-06 1994-05-24 Kao Corp 浴剤組成物
EP0866697A4 (en) * 1996-07-24 2006-01-18 Biosytes Usa Inc METHOD OF INCREASING THE SOLVENT PROPERTIES OF RELATIVELY UNLESHLY DIET ADDITIVES AND THESE PRODUCTS CONTAINING THEREOF
WO1998053797A3 (de) * 1997-05-28 1999-03-11 Ifac Inst Fuer Angewandte Coll Einkapseln von wasserunlöslichen wirkstoffen mit amphiphilem charakter
JP2011121974A (ja) * 2003-03-28 2011-06-23 Sigmoid Pharma Ltd シームレスマイクロカプセルを含む固形経口剤形
JP2006521366A (ja) * 2003-03-28 2006-09-21 シグモイド・バイオテクノロジーズ・リミテッド シームレスマイクロカプセルを含む固形経口剤形
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
JP2008520563A (ja) * 2004-11-16 2008-06-19 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物
US8961958B2 (en) 2004-11-16 2015-02-24 Bioavailability, Inc High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use
JP2006306819A (ja) * 2005-05-02 2006-11-09 Kenji Nakamura シート状化粧料
JP5199665B2 (ja) * 2005-06-15 2013-05-15 株式会社カネカ コエンザイムｑ１０含有水溶性組成物及びその製法
US8388950B2 (en) 2005-06-15 2013-03-05 Kaneka Corporation Coenzyme Q10-containing water-soluble composition and process for production thereof
JP2007302585A (ja) * 2006-05-10 2007-11-22 Fuji Capsule Kk コエンザイムｑ１０含有飲食品及び医薬品
WO2008047559A1 (fr) 2006-10-16 2008-04-24 Freund Corporation Poudre fortement dispersible dans l'eau et son procédé de production
US9675558B2 (en) 2007-04-04 2017-06-13 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US9844513B2 (en) 2007-04-04 2017-12-19 Sigmoid Pharma Limited Oral pharmaceutical composition
US10434139B2 (en) 2007-04-04 2019-10-08 Sublimity Therapeutics Limited Oral pharmaceutical composition
US10434140B2 (en) 2007-04-04 2019-10-08 Sublimity Therapeutics Limited Pharmaceutical cyclosporin compositions
JPWO2009001786A1 (ja) * 2007-06-22 2010-08-26 株式会社カネカ 生理活性物質含有組成物
US9999651B2 (en) 2009-05-18 2018-06-19 Sigmoid Pharma Limited Composition comprising oil drops
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
US9821024B2 (en) 2010-11-25 2017-11-21 Sigmoid Pharma Limited Immunomodulatory compositions
US9950051B2 (en) 2012-07-05 2018-04-24 Sigmoid Pharma Limited Formulations
US10434138B2 (en) 2013-11-08 2019-10-08 Sublimity Therapeutics Limited Formulations
US10993987B2 (en) 2014-11-07 2021-05-04 Sublimity Therapeutics Limited Compositions comprising Cyclosporin

Also Published As

Publication number Publication date
JPH0474339B2 (enrdf_load_stackoverflow) 1992-11-26

Similar Documents

Publication Publication Date Title
JPS5813508A (ja) ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物
KR880000970B1 (ko) 생물학적 유용성이 높은 경구용 약학적 조성물의 제조방법
CA2193497C (en) Controlled release aqueous emulsion
ES2226976T3 (es) Formulaciones galenicas de fenofibrato y su procedimiento de obtencion.
JP4429590B2 (ja) ユビキノン含有水可溶性組成物
JPS6230965B2 (enrdf_load_stackoverflow)
JP2002522473A5 (enrdf_load_stackoverflow)
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
JP2006511536A (ja) 水貧溶性薬物のバイオアベイラビリティーを改善する自由流動性固形製剤およびその製造方法
TW201114766A (en) Pharmaceutical composition for a hepatitis C viral protease inhibitor
KR102686709B1 (ko) 경구용 박막
US20040180961A1 (en) Compositions and preparation methods for bioavailable oral aceclofenac dosage forms
CA2281251C (en) Sterol esters in tableted solid dosage forms
JP4653810B2 (ja) ブチルフタリド自己乳化薬物送達システム、その調製方法および用途
EP3843706A1 (en) Vitamin d pediatric dosage forms, methods of making and using
JP2008510737A5 (enrdf_load_stackoverflow)
CN112353845B (zh) 含中药挥发油的热熔挤出组合物及其制备方法和药物制剂
JPH0354926B2 (enrdf_load_stackoverflow)
JPH0115A (ja) 吸収改善製剤
JP2012017326A (ja) 難溶物を含有するカプセルとその製造方法
CZ2002694A3 (cs) Biodostupná dávková forma isotretinoinu
JPS6351122B2 (enrdf_load_stackoverflow)
US5189066A (en) Pharmaceutical compositions of tebufelone
TW202128150A (zh) ３＇—［（２ｚ）—［１—（３，４—二甲基苯基）—１，５—二氫—３—甲基—５—側氧基—４ｈ—吡唑—４—亞基］肼基］—２＇—羥基—［１，１＇—聯苯基］—３—甲酸及其鹽配製物
WO2005046651A1 (en) Liquid filled capsules of doxycycline